Following PCZ treatment of tumor cells, an increase in EGF cell surface staining was observed, indicating a rise in the availability of cetuximab‐binding sites on the cell surface compared to untreated cells (Figure S5, Supporting Information). The gene discussed is EGF; the disease is neoplasm.